Literature DB >> 7827287

Cyclooxygenase inhibitors enhance tumour necrosis factor production and mortality in murine endotoxic shock.

E R Pettipher1, D J Wimberly.   

Abstract

Intraperitoneal administration of E. coli lipopolysaccharide (5-15 mg/kg) produced a dose-related increase in mortality which was maximal 72 h after induction of shock. Using a suboptimal dose of LPS (10 mg/kg i.p.), pretreatment with indomethacin (0.1-10 mg/kg p.o) or ibuprofen (1-100 mg/kg p.o) 30 min prior to induction of shock led to a significant enhancement of mortality. This enhancement was associated with a 2-3 fold increase in the peak circulating levels of tumour necrosis factor (TNF-alpha) in the serum of animals treated with indomethacin or ibuprofen compared to vehicle-treated control animals. These results indicate that TNF-alpha production is modulated by endogenous prostaglandins in vivo and that enhanced production of TNF-alpha by cyclooxygenase inhibitors may lead to exacerbation of some inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7827287     DOI: 10.1016/1043-4666(94)90077-9

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  8 in total

1.  Oral aspirin and ibuprofen increase cytokine-induced synthesis of IL-1 beta and of tumour necrosis factor-alpha ex vivo.

Authors:  S Endres; R E Whitaker; R Ghorbani; S N Meydani; C A Dinarello
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

2.  Regulation of tumour necrosis factor production by adrenal hormones in vivo: insights into the antiinflammatory activity of rolipram.

Authors:  E R Pettipher; J M Labasi; E D Salter; E J Stam; J B Cheng; R J Griffiths
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

Review 3.  Strategies to improve drug development for sepsis.

Authors:  Mitchell P Fink; H Shaw Warren
Journal:  Nat Rev Drug Discov       Date:  2014-09-05       Impact factor: 84.694

4.  Effect of cyclo-oxygenase inhibitors and modulators of cyclic AMP formation on lipopolysaccharide-induced neutrophil infiltration in mouse lung.

Authors:  V L Goncalves de Moraes; B Boris Vargaftig; J Lefort; A Meager; M Chignard
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

Review 5.  Cyclooxygenase inhibition in sepsis: is there life after death?

Authors:  David M Aronoff
Journal:  Mediators Inflamm       Date:  2012-05-14       Impact factor: 4.711

6.  Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo.

Authors:  J P Portanova; Y Zhang; G D Anderson; S D Hauser; J L Masferrer; K Seibert; S A Gregory; P C Isakson
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

7.  Carrageenan-induced acute inflammation in the mouse air pouch synovial model. Role of tumour necrosis factor.

Authors:  M Romano; R Faggioni; M Sironi; S Sacco; B Echtenacher; E Di Santo; M Salmona; P Ghezzi
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

Review 8.  Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection.

Authors:  Joëlle Micallef; Thomas Soeiro; Annie-Pierre Jonville-Béra
Journal:  Therapie       Date:  2020-05-07       Impact factor: 2.070

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.